Pharma & Biotech

Eli Lilly and Company is executing an ambitious growth strategy through simultaneous manufacturing expansion and clinical development. The pharmaceutical giant...

Despite posting disappointing quarterly results and facing continued share price pressure, market analysts are demonstrating notable optimism toward CareDx. The...

Shares of the biopharmaceutical firm Idorsia declined by 2.50% yesterday to close at CHF 4.09. This pullback occurred even as...

A wave of cautious optimism is beginning to emerge for Danish pharmaceutical giant Novo Nordisk following a prolonged period of...

After months of downward pressure, the life sciences giant Danaher is finally displaying encouraging signals. The critical question for investors...

A landmark licensing agreement has provided biotechnology firm Ocugen with a substantial confidence boost from investors. The company announced an...

The U.S. Food and Drug Administration (FDA) has launched a significant regulatory action, placing telehealth company Hims & Hers under...

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market...

While market headlines often focus on technology giants, a significant transformation is unfolding within the healthcare diagnostics sector. Quest Diagnostics,...